Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6. (Q33798516)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6. |
scientific article |
Statements
1 reference
Isoniazid mediates the CYP2B6*6 genotype-dependent interaction between efavirenz and antituberculosis drug therapy through mechanism-based inactivation of CYP2A6. (English)
1 reference
Ulrich M Zanger
1 reference
David J Greenblatt
1 reference
Michael H Court
1 reference
Suwagmani Hazarika
1 reference
Awewura Kwara
1 reference
Fawziah E Almutairi
1 reference
Hongyan Sheng
1 reference
Kathrin Klein
1 reference
Joanne Bourgea
1 reference
Christopher J Patten
1 reference
12 May 2014
1 reference
1 reference
58
1 reference
4145-4152
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference